HRTS Holdings — Tema Heart & Health ETF
All 45 reported holdings of Tema Heart & Health ETF (HRTS) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co | 11.52% | $5.98M |
| UnitedHealth Group Inc | 5.24% | $2.72M |
| Novo Nordisk A/S | 5.24% | $2.72M |
| Roche Holding AG | 4.50% | $2.33M |
| Merck & Co Inc | 4.27% | $2.22M |
| AstraZeneca PLC | 4.00% | $2.08M |
| Thermo Fisher Scientific Inc | 3.97% | $2.06M |
| Johnson & Johnson | 3.59% | $1.86M |
| Gilead Sciences Inc | 3.43% | $1.78M |
| Novartis AG | 3.38% | $1.76M |
| Revolution Medicines Inc | 3.33% | $1.73M |
| Vertex Pharmaceuticals Inc | 2.93% | $1.52M |
| Danaher Corp | 2.66% | $1.38M |
| Abbott Laboratories | 2.61% | $1.35M |
| Bridgebio Pharma Inc | 2.59% | $1.35M |
| Cytokinetics Inc | 2.52% | $1.31M |
| AbbVie Inc | 2.40% | $1.24M |
| Bristol-Myers Squibb Co | 2.09% | $1.08M |
| Teva Pharmaceutical Industries | 2.06% | $1.07M |
| Dexcom Inc | 1.92% | $996.37K |
| Amgen Inc | 1.91% | $992.18K |
| Medtronic PLC | 1.88% | $974.51K |
| Edwards Lifesciences Corp | 1.75% | $906.90K |
| McKesson Corp | 1.71% | $887.96K |
| Regeneron Pharmaceuticals Inc | 1.67% | $865.61K |
| Madrigal Pharmaceuticals Inc | 1.46% | $755.35K |
| Boston Scientific Corp | 1.42% | $738.42K |
| Chugai Pharmaceutical Co Ltd | 1.33% | $689.52K |
| Intuitive Surgical Inc | 1.30% | $675.18K |
| Alnylam Pharmaceuticals Inc | 1.14% | $590.07K |
| Arrowhead Pharmaceuticals Inc | 1.09% | $564.07K |
| Scholar Rock Holding Corp | 0.92% | $475.60K |
| Xenon Pharmaceuticals Inc | 0.88% | $459.35K |
| Ionis Pharmaceuticals Inc | 0.82% | $428.32K |
| Insulet Corp | 0.79% | $410.90K |
| Ascendis Pharma A/S | 0.76% | $393.31K |
| First American Treasury Obliga | 0.72% | $373.50K |
| Insmed Inc | 0.71% | $368.73K |
| Stoke Therapeutics Inc | 0.60% | $310.61K |
| Viking Therapeutics Inc | 0.54% | $279.53K |
| MBX Biosciences Inc | 0.53% | $275.71K |
| Zealand Pharma A/S | 0.52% | $268.38K |
| Gubra A/S | 0.48% | $250.27K |
| Intellia Therapeutics Inc | 0.38% | $195.46K |
| Structure Therapeutics Inc | 0.35% | $180.30K |
HRTS overview: performance, fees, allocation and SEC filings